Correlation Between Spectrascience New and Nephros
Can any of the company-specific risk be diversified away by investing in both Spectrascience New and Nephros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spectrascience New and Nephros into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spectrascience New and Nephros, you can compare the effects of market volatilities on Spectrascience New and Nephros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spectrascience New with a short position of Nephros. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spectrascience New and Nephros.
Diversification Opportunities for Spectrascience New and Nephros
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Spectrascience and Nephros is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Spectrascience New and Nephros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nephros and Spectrascience New is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spectrascience New are associated (or correlated) with Nephros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nephros has no effect on the direction of Spectrascience New i.e., Spectrascience New and Nephros go up and down completely randomly.
Pair Corralation between Spectrascience New and Nephros
Given the investment horizon of 90 days Spectrascience New is expected to generate 15.06 times more return on investment than Nephros. However, Spectrascience New is 15.06 times more volatile than Nephros. It trades about 0.06 of its potential returns per unit of risk. Nephros is currently generating about 0.04 per unit of risk. If you would invest 0.00 in Spectrascience New on November 2, 2024 and sell it today you would earn a total of 0.00 from holding Spectrascience New or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 95.95% |
| Values | Daily Returns |
Spectrascience New vs. Nephros
Performance |
| Timeline |
| Spectrascience New |
| Nephros |
Spectrascience New and Nephros Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spectrascience New and Nephros
The main advantage of trading using opposite Spectrascience New and Nephros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spectrascience New position performs unexpectedly, Nephros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nephros will offset losses from the drop in Nephros' long position.The idea behind Spectrascience New and Nephros pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Nephros vs. Precision Optics, | Nephros vs. Repro Med Systems | Nephros vs. InfuSystems Holdings | Nephros vs. Utah Medical Products |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |